AUA counters mainstream recommendations with new best practice statement on P... (ends that the benefits and risks of scre...)

AUA counters mainstream recommendations with new best practice statement on PSA testing

Date:4/26/2009

ends that the benefits and risks of screening of prostate cancer should be discussed including the risk of over-detection, detecting some cancers which may not need immediate treatment

"The single most important message of this statement is that prostate cancer testing is an individual decision that patients of any age should make in conjunction with their physicians and urologists. There is no single standard that applies to all men, nor should there be at this time," Dr. Carroll said. He also notes that the "panel carefully reviewed the most recently reported trials of PSA testing in both the United States and Europe before finalizing their guidelines. The strengths and limitations of these trials are reviewed in the guideline."

In regard to biopsy, a continuum of risk exists at all values, and major studies have demonstrated that there is no safe PSA value below which a man may be reassured that he does not have biopsy-detectable prostate cancer. Therefore, the AUA does not recommend a single PSA threshold at which a biopsy should be obtained. Rather, the decision to biopsy should take into account additional factors, including free and total PSA, PSA velocity and density, patient age, family history, race/ethnicity, previous biopsy history and co-morbidities. Additionally, the AUA statement emphasizes that not all prostate cancers require active treatment and that not all prostate cancers are life-threatening. The decision to proceed to active treatments is one that men should discuss in detail with their urologists to determine whether active treatment is necessary, or whether surveillance may be an option for their prostate cancer.

"Prostate cancer comes in many forms, some aggressive and some not," said Peter Carroll, MD, chair of the panel that developed the Statement. "But the bottom line about prostate cancer testing is that we cannot counsel patients about next steps for cancer that we do not know exist." He also notes that "the
'/>"/>

Contact: Wendy Isett
wisett@auanet.org
410-977-4770
American Urological Association
Source:Eurekalert

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. Draeger Counters What It Believes Are Unsubstantiated Allegations of Patent Infringement by Sperian
2. Inaugural Big Expedition for Cancer Research Encounters Mountain As Challenging As Finding a Cure for Cancer
3. RealSelf.com Denies Lifestyle Lifts Trademark Claims and Files Countersuit
4. Health and Fashion - Dow Corning Predicts the Top Trends Driving Consumers to the Beauty Counters
5. Alvarado Hospital Files Countersuit Against Blue Shield
6. Align Technology Targets Mainstream Orthodontics Market With Invisalign Teen(TM)
7. NARALS CHOICE: Is Anyone Surprised About Out-of-the-Mainstream NARALs Choice of Barack Obama for President?
8. Trust for Americas Health Supports Recommendations from Robert Wood Johnson Foundation Commission to Build a Healthier America
9. National Council on Disability Makes Recommendations to Create More Federal Job Opportunities for People With Disabilities
10. Coalition to Protect Senior Care Urges House Ways and Means Panel to Reject MedPAC Recommendations on SNF Medicare Funding
11. AHRQ Issues Recommendations for Safeguarding Children During Public Health Emergencies

Post Your Comments:

(Date:12/17/2009)... Helped, Healed, and Preserved Good Health , ... ... Association (IHRSA) announced today that as part of its Campaign for ... abilities to make 2010 the year we unite in a national ... daily exercise is highly valued and widely practiced. IHRSA is inviting ...

(Date:12/17/2009)... , , THURSDAY, Dec. 17 (HealthDay News) -- Among teenage ... least one of three common sexually transmitted infections -- ... becoming sexually active, a new study has found. , ... also found that it was common for these patients ... within four to six months after treatment of the ...

(Date:12/17/2009)... of Science in Human Resource Development Degree Online , ... ... -- Open enrollment has begun for Villanova’s newly online ... professionals whose busy schedules can’t accommodate a campus-based program. With ... online in March 2010, location is no longer a barrier ...

(Date:12/17/2009)... SAN DIEGO, Dec. 17 Neurocrine Biosciences, Inc. ... entered into a privately negotiated transaction to sell an ... to affiliates of Venrock at a price of $2.09 ... approximately $10 million. Neurocrine expects the financing to close ... closing conditions. ,, A shelf registration statement ...

(Date:12/17/2009)... Procedure Provides Efficient Mechanism to Pursue Approval ... Dec. 17 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: ... it has initiated the regulatory approval process ... under the Decentralized Procedure (DCP). The DCP ... company to simultaneously pursue regulatory approval for ...

Breaking Medicine News(10 mins):Health News:IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active 2 Health News:IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active 3 Health News:IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active 4 Health News:IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active 5 Health News:STDs Common Among Sexually Active Teen Girls in Cities 2 Health News:A World-Class HR Master's Degree Is Now Within Reach – 100% Online 2 Health News:A World-Class HR Master's Degree Is Now Within Reach – 100% Online 3 Health News:Neurocrine Announces Sale of 4,784,689 Shares of Common Stock, to Raise Proceeds of $10 Million 2 Health News:Neurocrine Announces Sale of 4,784,689 Shares of Common Stock, to Raise Proceeds of $10 Million 3 Health News:Labopharm Initiates Regulatory Approval Process for Twice-Daily Tramadol-Acetaminophen in Europe 2 Health News:Labopharm Initiates Regulatory Approval Process for Twice-Daily Tramadol-Acetaminophen in Europe 3

[0] IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active [0] STDs Common Among Sexually Active Teen Girls in Cities [0] A World-Class HR Master's Degree Is Now Within Reach – 100% Online [0] Neurocrine Announces Sale of 4,784,689 Shares of Common Stock, to Raise Proceeds of $10 Million [0] Labopharm Initiates Regulatory Approval Process for Twice-Daily Tramadol-Acetaminophen in Europe

... aspiring nurses about careers and online education. , ... ... the recent launch of their new website, online nursing degree ... their goal of connecting students with schools, Online Nursing Career also ...

... (Nasdaq: JAZZ ) announced today that the company ... November 11, 2008 at 2:50 p.m. EST, Dr. Samuel ... at the,Rodman & Renshaw 10th Annual Healthcare Conference in ... at 3:30 p.m. MST (5:30 p.m. EST), Dr.,Saks will ...

... of Zyvox and Cubicin is Driven Strongly ... a New Report from AMR and Decision,Resources, ... 4 Arlington,Medical Resources (AMR) and Decision Resources ... infections caused by methicillin-resistant Staphylococcus,aureus (MRSA), an ...

... Be Sold by A Uniquely-Trained Sales ... ... PSK) today announced that SANCUSO(R) (Granisetron Transdermal System),is now available by prescription ... was approved by,the U.S. Food and Drug Administration (F.D.A.) in September 2008 ...

... /PRNewswire-FirstCall/ Medizone International,Inc. (Pink Sheets: MZEI) announces ... TDV Global, Inc. (TDVGlobal.com). TDV Global,is a ... Approximately 70% of their business involves consulting ... private enterprise,mostly in the Health and Security ...

... rates far below goals, study finds , , TUESDAY, Nov. ... asthma and other high-risk illnesses are getting flu shots, ... from 1992 to 2002 for 18,703 adolescents with asthma, ... During the study period, vaccination rates improved, but only ...

Other Medicine News:Health News:Online Nursing Degree Seekers Gain a New Education Resource: OnlineNursingCareer.com 2 Health News:Activity Against MRSA is the Most Important Attribute Influencing Physicians' Antibiotic Selection for the Treatment of Skin and Skin Structure Infections 2 Health News:Activity Against MRSA is the Most Important Attribute Influencing Physicians' Antibiotic Selection for the Treatment of Skin and Skin Structure Infections 3 Health News:SANCUSO(R), the First and Only Patch for Preventing Nausea and Vomiting in Chemotherapy Patients, Now Available 2 Health News:SANCUSO(R), the First and Only Patch for Preventing Nausea and Vomiting in Chemotherapy Patients, Now Available 3 Health News:Medizone International, Inc. Announces Strategic Consulting Relationship With TDV Global, Inc. 2 Health News:Too Many High-Risk Teens Not Getting Flu Shots 2

Online Nursing Degree Seekers Gain a New Education Resource: OnlineNursingCareer.com Jazz Pharmaceuticals to Present at Investor Conferences Activity Against MRSA is the Most Important Attribute Influencing Physicians' Antibiotic Selection for the Treatment of Skin and Skin Structure Infections SANCUSO(R), the First and Only Patch for Preventing Nausea and Vomiting in Chemotherapy Patients, Now Available Medizone International, Inc. Announces Strategic Consulting Relationship With TDV Global, Inc.Too Many High-Risk Teens Not Getting Flu Shots

(Date:12/17/2009)... RALEIGH, N.C., Dec. 17 Pharmaceutical Institute ... from GeneEd, Inc., a company specializing in life ... advanced e-courses, help expand Pharmaceutical Institute,s already extensive ... Institute is a leading provider of specialized training ... a subsidiary of Campbell Alliance. Financial terms ...

(Date:12/17/2009)... PHOENIX, Dec. 17 The Make-A-Wish Foundation ... million donation from the LATISSE ® ... sponsored by Allergan, Inc. ,, Based on the ... a wish come true, the campaign launched earlier ... the Make-A-Wish Foundation by leveraging the excitement around ...

(Date:12/16/2009)... Cell Therapeutics, Inc. (CTI) (Nasdaq ... February 10, 2010 the U.S. Food and ... will review the New Drug Application (NDA) ... aggressive non-Hodgkin,s lymphoma (NHL). ODAC is an ... concerning the efficacy and safety of marketed ...

[0] Pharmaceutical Institute Acquires E-Learning Assets from GeneEd, Inc.[0] The Make-A-Wish Foundation(R) Receives $1 Million Donation from LATISSE(R) Wishes Campaign [0] Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010

... at least 45% additional,reduction in patients' LDL-cholesterol ... May 17, 2007 /PRNewswire-FirstCall/ -- Isis,Pharmaceuticals, Inc. ... clinical trial of ISIS 301012 in patients ... which were,presented in March at the of ...

... 17, 2007 - BioLineRx Ltd. (TASE:,BLRX), Israel's ... containing data from its successfully completed,phase I ... GABA-enhanced,antipsychotic for the treatment of schizophrenia, have ... scientific,conferences. The data will be presented at ...

Other Medicine Technology:Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 2 Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 3 Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 4 Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 5 BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming,Clinical Conferences 2 BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming,Clinical Conferences 3

Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming,Clinical Conferences

Modular Specimen Filing System has five cells that can hold either slides or tissue cassettes....

Shandon Microscope Slide Cabinet with Drawers...

... is the first solid-state,photocoagulator to ... wavelengths. This advanced,laser system makes ... a red or green wavelength,during ... and ensures effective,patient results., For ...

... The PSL utilizes a high luminance white LED ... lightweight, compact design, to give you the freedom ... The PSL Slit Lamp weighs only about 1.5 ... easily and comfortably in your hand. Its ...

Medicine Products:

Shandon Modular Filing System Shandon Microscope Slide Cabinet with Drawers Integre Duo Red and Green Solid State Photocoagulator PSL Portable Slit Lamp

AUA counters mainstream recommendations with new best practice statement on P...(ends that the benefits and risks of scre...),Health